(c) 2024 PillSync.com

Cephalexin 500 MG Oral Capsule

INDICATIONS AND USAGE Cephalexin is indicated for the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infections caused by Streptococcus pneumoniae and Streptococcus pyogenes (Penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. Cephalexin is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cephalexin in the subsequent prevention of rheumatic fever are not available at present.) Otitis media due to Streptococcus pneumoniae, Haemophilus influenzae , Staphylococcus aureus , Streptococcus pyogenes , and Moraxella catarrhalis Skin and skin structure infections caused by Staphylococcus aureus and/or Streptococcus pyogenes Bone infections caused by Staphylococcus aureus and/or Proteus mirabilis Genitourinary tract infections, including acute prostatitis, caused by Escherichia coli, Proteus mirabilis, and Klebsiella pneumoniae Note —Culture and susceptibility tests should be initiated prior to and during therapy. Renal function studies should be performed when indicated. To reduce the development of drug-resistant bacteria and maintain the effectiveness of cephalexin capsules, cephalexin for oral suspension, cephalexin tablets, and other antibacterial drugs, cephalexin capsules, cephalexin for oral suspension, and cephalexin tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

State of Florida DOH Central Pharmacy


4 years ago CAPSULE ORANGE 93 3147 Cephalexin 500 MG Oral Capsule

CAPSULE ORANGE 93 3147

HOW SUPPLIED Cephalexin capsules USP— 250 mg: bottles of 20, 40, 100, 500 and Unit Dose cartons of 60 (15 x 4) and 100 (10 x 10). capsule identification number and color: “93” - “3145,” gray cap and swedish orange body. 500 mg: bottles of 20, 40, 100, 250, 500 and Unit Dose cartons of 60 (15 x 4) and 100 (10 x 10). capsule identification number and color: “93” - “3147,” swedish orange cap and body. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Cephalexin for oral suspension* USP (a mixed berry-flavored formula)— 125 mg/5 mL: bottles of 60 mL, 100 mL and 200 mL. 250 mg/5 mL: bottles of 100 mL and 200 mL. Directions for mixing are included on the label. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. * After mixing, store in refrigerator. May be kept for 14 days without significant loss of potency. Shake well before using. Keep tightly closed. Cephalexin tablets USP— 250 mg: bottles of 20, 100 and 500. Tablet identification number and color: white, capsule-shaped tablet, debossed “93” on one side, with a score between the “9” and the “3”, and debossed “2238” on the reverse side. 500 mg: bottles of 20, 100 and 500. Tablet identification number and color: white, capsule-shaped tablet, debossed “93” on one side, with a score between the “9” and the “3”, and debossed “2240” on the reverse side. Store dry powder at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. They are supplied by State of Florida DOH Central Pharmacy as follows: NDC Strength Quantity/Form Color Source Prod. Code 53808-0222-1 500 mg 30 Canisters in a Blister Pack swedish orange 0093-3147


More pills like CAPSULE 93 3147

Related Pills

Cephalexin 500 MG Oral Capsule

State of Florida DOH Central Pharmacy












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site